In a paper published in Nature, researchers from Mass General Brigham used preclinical models to uncover Tim-3's role in microglia, the brain's resident immune cells, and have identified it as a ...

Mizuho raised the firm’s price target on Quest Diagnostics (DGX) to $189 from $178 and keeps an Outperform rating on the shares. The firm surveyed 215 physicians over 13 specialties to gauge ...

the brain's resident immune cells, and have identified it as a promising therapeutic target for AD. "Immune checkpoint inhibitors have revolutionized cancer immunotherapy, and it is exciting that ...

the brain's resident immune cells, and have identified it as a promising therapeutic target for Alzheimer’s disease. “Immune checkpoint inhibitors have revolutionized cancer immunotherapy ...

highlighting the rmPFC as a compelling target for transcranial magnetic stimulation. “Identifying a common brain circuit causally involved in psychotic symptoms suggests that the hippocampus may ...

Out on the tiny islands of St. Pierre and Miquelon, locals spent the past few days trying to get to the bottom of a perplexing mystery: Who sold so much stuff to a buyer or buyers in the U.S. that ...

While these enzymes play important roles in brain function, they can also contribute to AD progression when they attach to plaques. Drugs that target these enzymes are already used to help with ...

Researchers chose to focus on smell due to the fact that the areas of the brain responsible for processing smells are among the first affected by Alzheimer's disease. The study highlighted that ...

Therefore, CRFBP may represent a valuable target to treat stress-related illness, including: development of novel medications to treat AUD and restore homeostasis in the aging brain. This narrative ...